Thursday’s ETF Movers: Gold Miner Bulls, Long Silver ETN

The markets are slightly down on late Thursday after a big rise on Wednesday, following the FOMC press release. The Dow Jones Industrial Average (INDEXDJX:.DJI) and the S&P 500 INDEX (INDEXCBOE:SPX) declined by 0.08% and 0.07%, respectively. On the opposite, COMEX Gold is up 3.85% and now trades around $1321.70 per troy ounce. Among the top stock gainers are: The Kroger Co. (NYSE:KR), which rose 5.4% and continues to gain ground, and Celgene Corporation (NASDAQ:CELG) is up about 4%.


Direxion Daily Jr Gld Mnrs Bull 3X Shrs (NYSEARCA:JNUG), which holds long positions in securities from the Market Vectors Junior Gold Miners Index, has been Tuesday’s biggest loser. However, it recouped on late Wednesday, and continued to rise throughout Thursday’s trading. The ETF is up about 22% today, after a rough month, responding to the increase in the gold prices, most likely. It currently trades at $30.23. Direxion Daily Gold Miners Bull 3X Shrs (NUGT)’s case is quite similar. The ETF gained more than 15% today, and now trades around $44.17.

Market Vectors Junior Gold Miners ETF (NYSEARCA:GDXJ) is also amongst the outperformers, having returned 7.2% today. This fund seeks to replicate the Market Vectors® Global Junior Gold Miners Index, and has returned almost 10% year-to-date.

VelocityShares 3x Long Silver ETN (NYSEARCA:USLV) is another one of the big winners today. This ETF that seeks to replicate three times the S&P GSCI Silver index ER gained more than 15% on Thursday’s trading. As you might figure, VelocityShares 3x Inverse Silver ETN (NYSEARCA:DSLV), which replicated three times the opposite (inverse) of the S&P GSCI Silver index ER, lost about 14% today.

On the opposite sidewalk, iShares MSCI Frontier 100 (NYSEARCA:FM) lost about 1.2% in Thursday afternoon trading. The investment seeks to track the investment results of an index composed of frontier market equities.

Direxion Daily Gold Miners Bear 3X Shrs (NYSEARCA:DUST) was the underdog today, having lost almost 15%, as the gold price continues to rise.

Disclosure: Javier Hasse holds no interest in any stocks or ETFs mentioned

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!